title: Response to: Demarteau N, Standaert B. Modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer. J Med Econ 2010;13:324-38.
authors.forename: Peter
authors.initials: P
authors.lastname: Hillemanns
mesh_terms: D003218:Condylomata Acuminata / Q000191:economics / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D005260:Female; D005858:Germany; D006801:Humans; D053918:Papillomavirus Vaccines / Q000191:economics*; D019057:Quality-Adjusted Life Years; D002583:Uterine Cervical Neoplasms / Q000191:economics* / Q000517:prevention & control
chemical_list: D053918:Papillomavirus Vaccines